Trials / Completed
CompletedNCT00132665
Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)
Randomized Controlled Trial to Evaluate Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatine in Elderly Patients With Locally Advanced Non-small Cell Lung Cancer (JCOG0301, NCSLC-Elderly-CBDCA-RT Phase III)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Japan Clinical Oncology Group · Academic / Other
- Sex
- All
- Age
- 71 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether radiotherapy with carboplatin will result in longer survival than radiotherapy alone in elderly patients with unresectable stage III NSCLC.
Detailed description
The purpose of this study is to evaluate whether radiotherapy with carboplatin will result in longer survival than radiotherapy alone in elderly patients with unresectable stage III NSCLC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | A: Radiotherapy alone | Procedure/Surgery: A: Radiotherapy alone |
| DRUG | B: CBDCA and Radiotherapy | Drug: B: CBDCA and Radiotherapy |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2011-11-01
- Completion
- 2012-02-01
- First posted
- 2005-08-22
- Last updated
- 2012-12-07
Locations
37 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00132665. Inclusion in this directory is not an endorsement.